References analysis of the Wikipedia article "조절 T세포" in the Korean version

doi.org

dx.doi.org

Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, 외. (May 2006). “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells”. 《Nature》 441 (7090): 235–8. Bibcode:2006Natur.441..235B. doi:10.1038/nature04753. PMID 16648838.

Curiel TJ (May 2007). “Tregs and rethinking cancer immunotherapy”. 《The Journal of Clinical Investigation》 117 (5): 1167–74. doi:10.1172/JCI31202. PMC 1857250. PMID 17476346.

Chen W (August 2011). “Tregs in immunotherapy: opportunities and challenges”. 《Immunotherapy》 3 (8): 911–4. doi:10.2217/imt.11.79. PMID 21843075.

Hori S, Nomura T, Sakaguchi S (February 2003). “Control of regulatory T cell development by the transcription factor Foxp3”. 《Science》 299 (5609): 1057–61. Bibcode:2003Sci...299.1057H. doi:10.1126/science.1079490. PMID 12522256.

Shevach EM (2000). “Regulatory T cells in autoimmmunity*”. 《Annual Review of Immunology》 18: 423–49. doi:10.1146/annurev.immunol.18.1.423. PMID 10837065.

Schmetterer KG, Neunkirchner A, Pickl WF (June 2012). “Naturally occurring regulatory T cells: markers, mechanisms, and manipulation”. 《FASEB Journal》 26 (6): 2253–76. doi:10.1096/fj.11-193672. PMID 22362896.

Sakaguchi S (2004). “Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses”. 《Annual Review of Immunology》 22: 531–62. doi:10.1146/annurev.immunol.21.120601.141122. PMID 15032588.

Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z (October 2011). “Human FoxP3+ regulatory T cells in systemic autoimmune diseases”. 《Autoimmunity Reviews》 10 (12): 744–55. doi:10.1016/j.autrev.2011.05.004. PMID 21621000.

Nosbaum A, Prevel N, Truong HA, Mehta P, Ettinger M, Scharschmidt TC, 외. (March 2016). “Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing”. 《Journal of Immunology》 196 (5): 2010–4. doi:10.4049/jimmunol.1502139. PMC 4761457. PMID 26826250.

Adeegbe DO, Nishikawa H (2013). “Natural and induced T regulatory cells in cancer”. 《Frontiers in Immunology》 4: 190. doi:10.3389/fimmu.2013.00190. PMC 3708155. PMID 23874336.

Curiel TJ (April 2008). “Regulatory T cells and treatment of cancer”. 《Current Opinion in Immunology》 20 (2): 241–6. doi:10.1016/j.coi.2008.04.008. PMC 3319305. PMID 18508251.

Li MO, Rudensky AY (April 2016). “T cell receptor signalling in the control of regulatory T cell differentiation and function”. 《Nature Reviews. Immunology》 16 (4): 220–33. doi:10.1038/nri.2016.26. PMC 4968889. PMID 27026074.

Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Perals C, 외. (June 2015). “Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors”. 《Nature Immunology》 16 (6): 628–34. doi:10.1038/ni.3150. PMID 25939024.

Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ (December 2007). “CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells”. 《Nature Immunology》 8 (12): 1353–62. doi:10.1038/ni1536. PMID 17982458.

Cheng G, Yu A, Malek TR (May 2011). “T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells”. 《Immunological Reviews》 241 (1): 63–76. doi:10.1111/j.1600-065X.2011.01004.x. PMC 3101713. PMID 21488890.

Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Möwes B, Radbruch A, Thiel A (March 2002). “Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood”. 《The Journal of Experimental Medicine》 195 (6): 789–94. doi:10.1084/jem.20011756. PMC 2193736. PMID 11901204.

Toker A, Engelbert D, Garg G, Polansky JK, Floess S, Miyao T, 외. (April 2013). “Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus”. 《Journal of Immunology》 190 (7): 3180–8. doi:10.4049/jimmunol.1203473. PMID 23420886.

Nikolouli E, Elfaki Y, Herppich S, Schelmbauer C, Delacher M, Falk C, 외. (January 2021). “Recirculating IL-1R2⁺ T_reg fine-tune intrathymic T_reg development under inflammatory conditions”. 《Cellular & Molecular Immunology》 18 (1): 182–193. doi:10.1038/s41423-019-0352-8. hdl:10033/622148. PMC 7853075. PMID 31988493.

Peters VA, Joesting JJ, Freund GG (August 2013). “IL-1 receptor 2 (IL-1R2) and its role in immune regulation”. 《Brain, Behavior, and Immunity》 32: 1–8. doi:10.1016/j.bbi.2012.11.006. PMC 3610842. PMID 23195532.

Read S, Malmström V, Powrie F (July 2000). “Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation”. 《The Journal of Experimental Medicine》 192 (2): 295–302. doi:10.1084/jem.192.2.295. PMC 2193261. PMID 10899916.

Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, 외. (November 2007). “The inhibitory cytokine IL-35 contributes to regulatory T-cell function”. 《Nature》 450 (7169): 566–9. Bibcode:2007Natur.450..566C. doi:10.1038/nature06306. PMID 18033300.

Annacker O, Asseman C, Read S, Powrie F (June 2003). “Interleukin-10 in the regulation of T cell-induced colitis”. 《Journal of Autoimmunity》 20 (4): 277–9. doi:10.1016/s0896-8411(03)00045-3. PMID 12791312.

Kearley J, Barker JE, Robinson DS, Lloyd CM (December 2005). “Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent”. 《The Journal of Experimental Medicine》 202 (11): 1539–47. doi:10.1084/jem.20051166. PMC 1350743. PMID 16314435.

Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ (February 2005). “Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism”. 《Journal of Immunology》 174 (4): 1783–6. doi:10.4049/jimmunol.174.4.1783. PMID 15699103.

Puccetti P, Grohmann U (October 2007). “IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation”. 《Nature Reviews. Immunology》 7 (10): 817–23. doi:10.1038/nri2163. PMID 17767193.

Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, 외. (August 2007). “Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression”. 《Blood》 110 (4): 1225–32. doi:10.1182/blood-2006-12-064527. PMID 17449799.

Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR (November 2006). “T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine”. 《Journal of Immunology》 177 (10): 6780–6. doi:10.4049/jimmunol.177.10.6780. PMID 17082591.

Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, 외. (October 2004). “Role of LAG-3 in regulatory T cells”. 《Immunity》 21 (4): 503–13. doi:10.1016/j.immuni.2004.08.010. PMID 15485628.

Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, 외. (January 2009). “The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells”. 《Nature Immunology》 10 (1): 48–57. doi:10.1038/ni.1674. PMID 19011627.

Wardell CM, MacDonald KN, Levings MK, Cook L (January 2021). “Cross talk between human regulatory T cells and antigen-presenting cells: Lessons for clinical applications”. 《European Journal of Immunology》 51 (1): 27–38. doi:10.1002/eji.202048746. PMID 33301176.

Sakaguchi S, Yamaguchi T, Nomura T, Ono M (May 2008). “Regulatory T cells and immune tolerance”. 《Cell》 133 (5): 775–87. doi:10.1016/j.cell.2008.05.009. PMID 18510923.

Walker LS, Sansom DM (November 2011). “The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses”. 《Nature Reviews. Immunology》 11 (12): 852–63. doi:10.1038/nri3108. PMID 22116087.

Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, 외. (July 2011). “A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity”. 《Immunity》 35 (1): 109–22. doi:10.1016/j.immuni.2011.03.029. PMC 3295638. PMID 21723159.

Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y (August 2007). “Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid”. 《The Journal of Experimental Medicine》 204 (8): 1775–85. doi:10.1084/jem.20070602. PMC 2118682. PMID 17620362.

Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H (July 2007). “Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid”. 《Science》 317 (5835): 256–60. Bibcode:2007Sci...317..256M. doi:10.1126/science.1145697. PMID 17569825.

Erkelens MN, Mebius RE (March 2017). “Retinoic Acid and Immune Homeostasis: A Balancing Act”. 《Trends in Immunology》 38 (3): 168–180. doi:10.1016/j.it.2016.12.006. PMID 28094101.

Ziegler SF, Buckner JH (April 2009). “FOXP3 and the regulation of T_reg/T_h17 differentiation”. 《Microbes and Infection》 11 (5): 594–8. doi:10.1016/j.micinf.2009.04.002. PMC 2728495. PMID 19371792.

Povoleri GA, Nova-Lamperti E, Scottà C, Fanelli G, Chen YC, Becker PD, 외. (December 2018). “Human retinoic acid-regulated CD161⁺ regulatory T cells support wound repair in intestinal mucosa”. 《Nature Immunology》 19 (12): 1403–1414. doi:10.1038/s41590-018-0230-z. PMC 6474659. PMID 30397350.

Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F (August 2007). “A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism”. 《The Journal of Experimental Medicine》 204 (8): 1757–64. doi:10.1084/jem.20070590. PMC 2118683. PMID 17620361.

Cook L, Reid KT, Häkkinen E, de Bie B, Tanaka S, Smyth DJ, 외. (September 2021). “Induction of stable human FOXP3⁺ T_regs by a parasite-derived TGF-β mimic”. 《Immunology and Cell Biology》 99 (8): 833–847. doi:10.1111/IMCB.12475. PMC 8453874. PMID 33929751.

Johnston CJ, Smyth DJ, Kodali RB, White MP, Harcus Y, Filbey KJ, 외. (November 2017). “A structurally distinct TGF-β mimic from an intestinal helminth parasite potently induces regulatory T cells”. 《Nature Communications》 8 (1): 1741. Bibcode:2017NatCo...8.1741J. doi:10.1038/s41467-017-01886-6. PMC 5701006. PMID 29170498.

Smyth DJ, Harcus Y, White MP, Gregory WF, Nahler J, Stephens I, 외. (April 2018). “TGF-β mimic proteins form an extended gene family in the murine parasite Heligmosomoides polygyrus”. 《International Journal for Parasitology》 48 (5): 379–385. doi:10.1016/j.ijpara.2017.12.004. PMC 5904571. PMID 29510118.

White MP, Smyth DJ, Cook L, Ziegler SF, Levings MK, Maizels RM (September 2021). “The parasite cytokine mimic Hp-TGM potently replicates the regulatory effects of TGF-β on murine CD4⁺ T cells”. 《Immunology and Cell Biology》 99 (8): 848–864. doi:10.1111/IMCB.12479. PMID 33988885.

Stringari LL, Covre LP, da Silva FD, de Oliveira VL, Campana MC, Hadad DJ, 외. (July 2021). “Increase of CD4+CD25highFoxP3+ cells impairs in vitro human microbicidal activity against Mycobacterium tuberculosis during latent and acute pulmonary tuberculosis”. 《PLOS Neglected Tropical Diseases》 15 (7): e0009605. doi:10.1371/journal.pntd.0009605. PMC 8321116. PMID 34324509.

Kleinman AJ, Sivanandham R, Pandrea I, Chougnet CA, Apetrei C (2018). “Regulatory T Cells As Potential Targets for HIV Cure Research”. 《Frontiers in Immunology》 9: 734. doi:10.3389/fimmu.2018.00734. PMC 5908895. PMID 29706961.

Sivanandham R, Kleinman AJ, Sette P, Brocca-Cofano E, Kilapandal Venkatraman SM, Policicchio BB, 외. (September 2020). “Nonhuman Primate Testing of the Impact of Different Regulatory T Cell Depletion Strategies on Reactivation and Clearance of Latent Simian Immunodeficiency Virus”. 《Journal of Virology》 94 (19): JVI.00533–20, jvi;JVI.00533–20v1. doi:10.1128/JVI.00533-20. PMC 7495362. PMID 32669326.

Dranoff G (December 2005). “The therapeutic implications of intratumoral regulatory T cells”. 《Clinical Cancer Research》 11 (23): 8226–9. doi:10.1158/1078-0432.CCR-05-2035. PMID 16322278.

Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM (October 2007). “CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells”. 《Blood》 110 (7): 2537–44. doi:10.1182/blood-2007-03-082578. PMC 1988926. PMID 17615291.

Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, 외. (March 2017). “ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity”. 《JCI Insight》 2 (5): e89530. doi:10.1172/jci.insight.89530. PMC 5333967. PMID 28289705.

Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, 외. (July 2018). “Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study”. 《Neurology》 5 (4): e465. doi:10.1212/NXI.0000000000000465. PMC 5961523. PMID 29845093.

Tsuda S, Nakashima A, Shima T, Saito S (2019). “New Paradigm in the Role of Regulatory T Cells During Pregnancy”. 《Frontiers in Immunology》 (영어) 10: 573. doi:10.3389/fimmu.2019.00573. PMC 6443934. PMID 30972068.

Hu M, Eviston D, Hsu P, Mariño E, Chidgey A, Santner-Nanan B, 외. (July 2019). “Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia”. 《Nature Communications》 10 (1): 3031. Bibcode:2019NatCo..10.3031H. doi:10.1038/s41467-019-10703-1. PMC 6620275. PMID 31292453.

Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (June 2011). “The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis”. 《British Journal of Cancer》 105 (1): 93–103. doi:10.1038/bjc.2011.189. PMC 3137407. PMID 21629244.

Oleinika K, Nibbs RJ, Graham GJ, Fraser AR (January 2013). “Suppression, subversion and escape: the role of regulatory T cells in cancer progression”. 《Clinical and Experimental Immunology》 171 (1): 36–45. doi:10.1111/j.1365-2249.2012.04657.x. PMC 3530093. PMID 23199321.

Plitas G, Rudensky AY (2020년 3월 9일). “Regulatory T Cells in Cancer”. 《Annual Review of Cancer Biology》 (영어) 4 (1): 459–477. doi:10.1146/annurev-cancerbio-030419-033428. ISSN 2472-3428.

Lippitz BE (May 2013). “Cytokine patterns in patients with cancer: a systematic review”. 《The Lancet. Oncology》 14 (6): e218–28. doi:10.1016/s1470-2045(12)70582-x. PMID 23639322.

Ezzeddini R, Somi MH, Taghikhani M, Moaddab SY, Masnadi Shirazi K, Shirmohammadi M, Eftekharsadat AT, Sadighi Moghaddam B, Salek Farrokhi A (February 2021). “Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients”. 《Cytokine》 138: 155351. doi:10.1016/j.cyto.2020.155351. ISSN 1043-4666. PMID 33127257.

Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, 외. (February 2007). “Foxp3 occupancy and regulation of key target genes during T-cell stimulation”. 《Nature》 445 (7130): 931–5. Bibcode:2007Natur.445..931M. doi:10.1038/nature05478. PMC 3008159. PMID 17237765.

Ellis SD, McGovern JL, van Maurik A, Howe D, Ehrenstein MR, Notley CA (October 2014). “Induced CD8+FoxP3+ Treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor α and CD86”. 《Arthritis & Rheumatology》 66 (10): 2694–705. doi:10.1002/art.38761. PMID 24980778.

Seddiki N, Cook L, Hsu DC, Phetsouphanh C, Brown K, Xu Y, 외. (June 2014). “Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses”. 《European Journal of Immunology》 44 (6): 1644–61. doi:10.1002/eji.201344102. PMID 24752698.

Zaunders JJ, Munier ML, Seddiki N, Pett S, Ip S, Bailey M, 외. (August 2009). “High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)”. 《Journal of Immunology》 183 (4): 2827–36. doi:10.4049/jimmunol.0803548. PMID 19635903.

Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, 외. (January 2009). “Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue”. 《Cancer Research》 69 (2): 599–608. doi:10.1158/0008-5472.CAN-08-2361. PMID 19147574.

Agarwal A, Singh M, Chatterjee BP, Chauhan A, Chakraborti A (2014). “Interplay of T Helper 17 Cells with CD4(+)CD25(high) FOXP3(+) Tregs in Regulation of Allergic Asthma in Pediatric Patients”. 《International Journal of Pediatrics》 2014: 636238. doi:10.1155/2014/636238. PMC 4065696. PMID 24995020.

Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, 외. (August 2006). “Mast cells are essential intermediaries in regulatory T-cell tolerance”. 《Nature》 442 (7106): 997–1002. Bibcode:2006Natur.442..997L. doi:10.1038/nature05010. PMID 16921386.

Hui DJ, Basner-Tschakarjan E, Chen Y, Davidson RJ, Buchlis G, Yazicioglu M, 외. (September 2013). “Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes”. 《Molecular Therapy》 21 (9): 1727–37. doi:10.1038/mt.2013.166. PMC 3776637. PMID 23857231.

De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P, 외. (October 2008). “Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"”. 《Blood》 112 (8): 3303–11. doi:10.1182/blood-2008-02-138073. PMC 2569179. PMID 18660382.

Su Y, Rossi R, De Groot AS, Scott DW (August 2013). “Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se”. 《Journal of Leukocyte Biology》 94 (2): 377–83. doi:10.1189/jlb.0912441. PMC 3714563. PMID 23729499.

Cousens LP, Su Y, McClaine E, Li X, Terry F, Smith R, 외. (2013). “Application of IgG-derived natural T_reg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetes”. 《Journal of Diabetes Research》 2013: 621693. doi:10.1155/2013/621693. PMC 3655598. PMID 23710469.

Cousens LP, Mingozzi F, van der Marel S, Su Y, Garman R, Ferreira V, 외. (October 2012). “Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease”. 《Human Vaccines & Immunotherapeutics》 8 (10): 1459–64. doi:10.4161/hv.21405. PMC 3660767. PMID 23095864.

Cousens LP, Najafian N, Mingozzi F, Elyaman W, Mazer B, Moise L, 외. (January 2013). “In vitro and in vivo studies of IgG-derived T_reg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity”. 《Journal of Clinical Immunology》 33 (1): S43–9. doi:10.1007/s10875-012-9762-4. PMC 3538121. PMID 22941509.

Elyaman W, Khoury SJ, Scott DW, De Groot AS (2011). “Potential application of tregitopes as immunomodulating agents in multiple sclerosis”. 《Neurology Research International》 2011: 256460. doi:10.1155/2011/256460. PMC 3175387. PMID 21941651.

harvard.edu

adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

Curiel TJ (May 2007). “Tregs and rethinking cancer immunotherapy”. 《The Journal of Clinical Investigation》 117 (5): 1167–74. doi:10.1172/JCI31202. PMC 1857250. PMID 17476346.

Chen W (August 2011). “Tregs in immunotherapy: opportunities and challenges”. 《Immunotherapy》 3 (8): 911–4. doi:10.2217/imt.11.79. PMID 21843075.

Singh B, Schwartz JA, Sandrock C, Bellemore SM, Nikoopour E (November 2013). “Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells”. 《The Indian Journal of Medical Research》 138 (5): 591–4. PMC 3928692. PMID 24434314.

Shevach EM (2000). “Regulatory T cells in autoimmmunity*”. 《Annual Review of Immunology》 18: 423–49. doi:10.1146/annurev.immunol.18.1.423. PMID 10837065.

Adeegbe DO, Nishikawa H (2013). “Natural and induced T regulatory cells in cancer”. 《Frontiers in Immunology》 4: 190. doi:10.3389/fimmu.2013.00190. PMC 3708155. PMID 23874336.

Curiel TJ (April 2008). “Regulatory T cells and treatment of cancer”. 《Current Opinion in Immunology》 20 (2): 241–6. doi:10.1016/j.coi.2008.04.008. PMC 3319305. PMID 18508251.

Sakaguchi S, Yamaguchi T, Nomura T, Ono M (May 2008). “Regulatory T cells and immune tolerance”. 《Cell》 133 (5): 775–87. doi:10.1016/j.cell.2008.05.009. PMID 18510923.

Erkelens MN, Mebius RE (March 2017). “Retinoic Acid and Immune Homeostasis: A Balancing Act”. 《Trends in Immunology》 38 (3): 168–180. doi:10.1016/j.it.2016.12.006. PMID 28094101.

Dranoff G (December 2005). “The therapeutic implications of intratumoral regulatory T cells”. 《Clinical Cancer Research》 11 (23): 8226–9. doi:10.1158/1078-0432.CCR-05-2035. PMID 16322278.

Lippitz BE (May 2013). “Cytokine patterns in patients with cancer: a systematic review”. 《The Lancet. Oncology》 14 (6): e218–28. doi:10.1016/s1470-2045(12)70582-x. PMID 23639322.

Online Mendelian Inheritance in Man IPEX

ipex - NIH/UW GeneTests

worldcat.org

조절 T세포 (Korean Wikipedia)

doi.org

dx.doi.org

epivax.com

fiercebiotechresearch.com

handle.net

hdl.handle.net

harvard.edu

adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

sciencedirect.com

worldcat.org

zenodo.org